首页 › 基金 › Birchview Capital, LP › RARE
Birchview Capital, LP 对 RARE 的持仓历史
ULTRAGENYX PHARMACEUTICAL IN · 医疗保健
Birchview Capital, LP 在 Q3 2026 的 13F 申报中披露持有 RARE(ULTRAGENYX PHARMACEUTICAL IN)373,671 股,市值约 US$5.6M,约占其申报组合的 3.34%,在其申报持仓中市值排名第 7 位。 Birchview Capital, LP 最近 8 个申报季度中有 7 个季度披露了 RARE 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Birchview Capital, LP 对 RARE 的持仓演变
Birchview Capital, LP 于 Q4 2024 首次披露 RARE 持仓:16,000 股(约 US$673K)。 该持仓在 Q3 2026 达到峰值 373,671 股,市值约 US$5.6M。 在 7 次申报中,Birchview Capital, LP 3 次增持、0 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 373,671 股、市值约 US$5.6M。 持仓曾出现大幅变动:Q4 2025 增持约 182% (随后一个季度股价下跌 9%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 16.00K | $673.12K | 新进 |
| Q1 2025 | 16.00K | $579.36K | 持有 |
| Q2 2025 | 18.00K | $654.48K | 增持 |
| Q3 2025 | 22.00K | $661.76K | 增持 |
| Q4 2025 | 62.00K | $1.43M | 增持 |
| Q1 2026 | 62.00K | $1.30M | 持有 |
| Q3 2026 | 373.67K | $5.62M | 新进 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RARE 与 13F 数据
RARE(ULTRAGENYX PHARMACEUTICAL IN)属于医疗保健行业。我们追踪的基金中还有 24 只申报持有 RARE,申报仓位最大的包括:RTW INVESTMENTS, LP (US$260.3M), FRONTIER CAPITAL MANAGEMENT CO LLC (US$95.1M), Bellevue Group AG (US$66.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RARE 的基金
- RTW INVESTMENTS, LP 7.80M 股 · $260.34M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 2.85M 股 · $95.09M · Q2 2026
- Bellevue Group AG 1.98M 股 · $66.20M · Q2 2026
- MPM BioImpact LLC 1.42M 股 · $47.35M · Q2 2026
- Nantahala Capital Management, LLC 2.34M 股 · $35.16M · Q3 2026
更多关于 Birchview Capital, LP
常见问题
How long has Birchview Capital, LP held RARE?
Birchview Capital, LP has disclosed RARE holdings in 7 of the last 8 reported quarters, going back to Q4 2024.
What is Birchview Capital, LP's current position in RARE?
As of Q3 2026, Birchview Capital, LP holds 373.67K shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), valued at $5.62M, representing 3.34% of its reported portfolio and ranking #7.
Has Birchview Capital, LP been buying or selling RARE?
In the latest 13F filing (Q3 2026), Birchview Capital, LP newly opened its position in RARE. The position peaked in Q3 2026 at 373.67K shares.
Which other funds hold RARE?
Other major institutional holders of RARE include RTW INVESTMENTS, LP, FRONTIER CAPITAL MANAGEMENT CO LLC, Bellevue Group AG, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.